Diagnostic Medical Systems S.A. (EPA:ALDMS)
France
· Delayed Price · Currency is EUR 1.001
-0.019 (-1.86%)
Apr 29, 2025, 11:45 AM CET
EPA:ALDMS Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -2.88 | -4.95 | -6.82 | -3.88 | -5.24 | Upgrade
|
| Depreciation & Amortization | -1.74 | 4.32 | 3.47 | 1.93 | 1.06 | Upgrade
|
| Other Amortization | 1.67 | - | - | - | 1.81 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.17 | 0.82 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 0.22 | 0.18 | - | Upgrade
|
| Other Operating Activities | 2.51 | 0.24 | 1.81 | 0.92 | -0.04 | Upgrade
|
| Change in Accounts Receivable | -1.69 | 0.29 | 0.87 | -0.29 | 1.82 | Upgrade
|
| Change in Inventory | 1.65 | -1.16 | -0.53 | 0.15 | -3.06 | Upgrade
|
| Change in Accounts Payable | 0.46 | -1.34 | 1.96 | 1.76 | -3.32 | Upgrade
|
| Change in Other Net Operating Assets | 3.62 | 0.95 | -0.02 | -2.02 | 2.45 | Upgrade
|
| Operating Cash Flow | 3.6 | -1.65 | 0.96 | -1.08 | -3.69 | Upgrade
|
| Capital Expenditures | -3.57 | -2.72 | -5.19 | -5.88 | -3.08 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.15 | 0.73 | 3.84 | - | Upgrade
|
| Divestitures | -0.15 | 0.03 | 1.37 | - | 7.7 | Upgrade
|
| Investment in Securities | - | - | - | -1.18 | 0 | Upgrade
|
| Other Investing Activities | 0.77 | 1.06 | - | 0.53 | - | Upgrade
|
| Investing Cash Flow | -2.9 | -1.48 | -3.09 | -2.7 | 4.62 | Upgrade
|
| Long-Term Debt Issued | 3.64 | 5.43 | 5.82 | 9.13 | 8.37 | Upgrade
|
| Long-Term Debt Repaid | -3.02 | -1.99 | -8.61 | -2.89 | -7.33 | Upgrade
|
| Net Debt Issued (Repaid) | 0.62 | 3.45 | -2.79 | 6.24 | 1.04 | Upgrade
|
| Issuance of Common Stock | 0.01 | 0.04 | 5.86 | - | - | Upgrade
|
| Other Financing Activities | -0.74 | - | - | - | - | Upgrade
|
| Financing Cash Flow | -0.11 | 3.48 | 3.08 | 6.24 | 1.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | 0 | - | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -0.69 | -0 | - | Upgrade
|
| Net Cash Flow | 0.59 | 0.36 | 0.25 | 2.46 | 1.97 | Upgrade
|
| Free Cash Flow | 0.03 | -4.37 | -4.23 | -6.96 | -6.77 | Upgrade
|
| Free Cash Flow Margin | 0.06% | -9.90% | -11.42% | -18.31% | -19.34% | Upgrade
|
| Free Cash Flow Per Share | 0.00 | -0.25 | -0.26 | -0.43 | -0.42 | Upgrade
|
| Levered Free Cash Flow | -2.83 | 3.56 | -11.25 | -5.36 | -4.13 | Upgrade
|
| Unlevered Free Cash Flow | -2.37 | 3.84 | -11.11 | -5.18 | -3.55 | Upgrade
|
| Change in Net Working Capital | -1.76 | -3.32 | 5.1 | 0.71 | 1.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.